title: Cyclosporine provides better success rates for both higher- and lower-risk cadaveric kidney transplant recipients.
authors.affiliation: Transplant Service, University of California San Francisco 94143.
authors.forename: N J
authors.initials: NJ
authors.lastname: Feduska
authors.forename: J S
authors.initials: JS
authors.lastname: Melzer
authors.forename: W J
authors.initials: WJ
authors.lastname: Amend
authors.forename: F
authors.initials: F
authors.lastname: Vincenti
authors.forename: S J
authors.initials: SJ
authors.lastname: Tomlanovich
authors.forename: M
authors.initials: M
authors.lastname: Garovoy
authors.forename: R
authors.initials: R
authors.lastname: Husing
authors.forename: O
authors.initials: O
authors.lastname: Salvatierra
mesh_terms: D001803:Blood Transfusion; D003524:Cyclosporins / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006084:Graft Rejection; D006801:Humans; D007165:Immunosuppression Therapy; D016030:Kidney Transplantation; D011241:Prednisone / Q000008:administration & dosage; D012307:Risk Factors
chemical_list: D003524:Cyclosporins; D011241:Prednisone